Astellas ISR Portal

New research proposal submissions for the following products, regionally, will be reviewed for consideration of support by Astellas.

Compound	Region/Country
avacincaptad pegol	Saudi Arabia United States
enfortumab vedotin	Asia (for country specific listing click here) Australia Europe (for country specific listing click here) Middle East United States (proposals will be reviewed jointly by Astellas and Pfizer)
enzalutamide	Asia (for country specific listing click here) Australia Canada Europe (for country specific listing click here) Japan Latin America (for country specific listing click here) Middle East and Africa (for country specific listing click here) Russian Federation Turkey United States (proposals will be reviewed jointly by Astellas and Pfizer)
gilteritinib	Asia (for country specific listing click here) Australia Canada Europe (for country specific listing click here) Japan Latin America (for country specific listing click here) United Arab Emirates
fezolinetant	APAC (for country specific listing click here) Canada Europe (for country specific listing click here) Latin America (for country specific listing click here) United States
mirabegron	Asia (for country specific listing click here) Russia
ipragliflozin	Japan
roxadustat	Australia and Canada (for country specific listing click here) Egypt Japan Russian Federation Saudi Arabia South Africa Turkey UAE
tacrolimus	China Europe (for country specific listing click here) Korea
zolbetuximab	APAC (for country specific listing click here) Canada Europe (for country specific listing click here) Latin America (for country specific listing click here) United States

Useful Hyperlinks
For investigators located in Europe, Israel, Canada: In case your grant application is approved,a contract will be required. Astellas will provide the contract that will contain several terms and conditions that are pre-defined. You can find these pre-defined terms and conditions here. Please be aware that this document is not the actual contract that will be proposed. Astellas does not have the capacity to re-negotiate these terms and conditions on a bespoke basis. Therefore,prior to submitting your application, please verify within your institution that these terms and conditions are acceptable.
To view, click on the link below: ISR AREAS OF INTEREST
For Japan products, please click here: https://www.astellas.com/jp/science/research-and-development/external-funding/research/investigator-sponsored-research

Useful Hyperlinks

For investigators located in Europe, Israel, Canada:

In case your grant application is approved,a contract will be required.
Astellas will provide the contract that will contain several terms and conditions that are pre-defined.
You can find these pre-defined terms and conditions here.
Please be aware that this document is not the actual contract that will be proposed. Astellas does not have the capacity to re-negotiate these terms and conditions on a bespoke basis.
Therefore,prior to submitting your application, please verify within your institution that these terms and conditions are acceptable.

To view, click on the link below:

ISR AREAS OF INTEREST

For Japan products, please click here:

https://www.astellas.com/jp/science/research-and-development/external-funding/research/investigator-sponsored-research

Please do not use this website to report safety information or product complaints. To report safety information or product complaints about an Astellas medicine, please email according to region: For EMEA (Europe, Middle East and Africa): safety-EU@astellas.com ; for Americas (Canada, USA and Latin America): safety-US@astellas.com ; or for Asia/Oceania (Japan, Australasia): safety-JP@astellas.com.

Welcome!

This is your place to manage all of your investigator-sponsored research with Astellas.